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 ABSTRACT                                                                                                                                            
Prenatal diagnosis of aneuploidy among a sample of 
Egyptian high risk pregnancies
Rabah M. Shawky1, Eman A. Zaky1, Ezzat S. El-Sobky1, Ahmad R. Ramy2 and 
Sherif Y. Omer3.
1Pediatric Department,2Obstetric and Gynecology Department, Ain Shams 
University, 3Medical Genetics Center
Background: A number of studies have shown that aneuploidies of only 5 
chromosomes (13, 18, 21, X and Y) account for about 65% of all chromosomal 
abnormalities and 95% of chromosomal aberrations cause live-born birth de-
fects. Fluorescent in-situ Hybridization (FISH) has been found to be highly 
effective for rapidly determining the number of specifi ed chromosomes in in-
terphase cells. 
Patients and Methods: Prenatal diagnosis was performed on 40 high risk 
pregnancies chosen from mothers attending the Antenatal Clinic of Ain Shams 
University Medical genetics Center (ASUMGC). Early amniocentesis for con-
ventional karyotype analysis of cultured amniocytes and interphase FISH stud-
ies of uncultured amniocytes for rapid detection of aneuploidies of chromo-
somes (13, 18, 21, X and Y) was performed. 
Results: Normal karyotype was detected in 35 cases (87.5%) and in 4 cases 
(10%) chromosomal abnormalities were detected by conventional karyotype. 
However, culture failed in one case (2.5%) due to culture contamination. FISH 
assay confi rmed the cytogenetic fi ndings, for the probes used, on interphase nu-
clei in all cases analysed, except three cases of structural chromosomal abnor-
malities: [46,XX, add 21(q22); 46,XX, t(5;20) mat, 46,XY, inv(9) (p11:q13)] 
paternal. In one case of culture contamination, FISH analysis was useful in 
excluding the aberrations of specifi c chromosomes 13, 18, 21, X and Y on the 
uncultured/interphase nuclei. 
Conclusion: Molecular cytogenetic technique of FISH is very useful in 
urgent cases of prenatal diagnosis where it can be used on uncultured 
amniocytes for rapid and accurate detection of common aneuploidies.




Aneuploidy, prenatal diagnosis, chro-
mosomal aberrations, amniocentesis, 
FISH. 
INTRODUTION                                          
Aneupliody is defi ned as nu-
merical abnormalities that in-
volve gain or loss of one or more 
chromosomes. Loss of a single chromo-
some results in monosomy while gain of 
one or two homologous chromosomes 
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Probes can be prepared for a whole 
chromosome. When such probes are 
applied to a metaphase spread they will 
hybridize to or paint all material origi-
nating from a particular chromosome1. 
FISH has been found to be highly effec-
tive for rapidly determining the number 
of specifi ed chromosomes in interphase 
cells.6
AIM OF THE STUDY                                                
The study aimed at determining the per-
centage of aneuoploidy in a sample of 
high risk pregnancies for prenatal diag-
nosis and comparing the results of con-
ventional karyotype analysis and FISH 
as two different modalities of prenatal 
diagnosis as regards rapidness of ob-
taining the results and their effective-
ness in diagnosis of aneuoploidy.
SUBJECTS AND METHODS                      
Prenatal diagnosis was performed 
in 40 high risk pregnancies chosen 
randomly from mothers attending 
the Antenatal Clinic of Ain Shams 
University Medical Genetics Center 
(ASUMGC), selection criteria were as 
follows: advanced maternal age (mater-
nal age above 35 years), previous child 
with chromosomal abnormality, fetal 
abnormality suggestive of aneuploidy 
detected through ultrasound examina-
tion, parental chromosomal abnormal-
ity and previous recurrent abortions.
For all enrolled cases the following were 
done: Detailed history taking, family 
pedigree construction, fi rst and second-
trimester ultrasound assessment, early 
amniocentesis for conventional karyo-
type analysis of cultured amniocytes 
and interphase FISH studies of uncul-
tured amniocytes.
is referred to as trisomy and tetrasomy, 
respectively.1 
A number of studies have shown that 
aneuploidies of only 5 chromosomes 
(13, 18, 21, X and Y) account for about 
65% of all chromosomal abnormalities 
and 95% of chromosomal aberrations 
causing live-born brith defects.2
In another study the incidence of all 
chromosomal abnormalities in very high 
risk pregnancies is relatively high with 
aneuploidies 13, 18, 21, X and Y being 
the most common fi nding (76%).3
Prenatal diagnosis of chromosomal 
anomalies employs a variety of tech-
niques either as a screening procedure 
for relatively prevalent disorders or as a 
diagnostic procedure for known familial 
conditions. The former identifi es an in-
creased likelihood of a fetal abnormal-
ity in an apparently normal pregnancy, 
whereas the latter confi rms or refutes 
the existence of an actual anomaly in a 
fetus believed to be at increased risk.4
Currently available prenatal non-inva-
sive screening tests include ultrasonog-
raphy and various biochemical tests 
(maternal marker screening), while 
chorionic villus sampling, amniocente-
sis and fetal blood sampling are inva-
sive diagnostic procedures. At present, 
these invasive procedures are consid-
ered as gold standards for the diagnosis 
of chromosomal anomalies or other ge-
netic diseases.5
Fluorescent in-situ Hybridization 
(FISH) relies on the unique ability of a 
portion of single stranded DNA, known 
as a probe to anneal or hybridize with 
its complementary target sequence 
wherever it is located in the genome. 
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The amniotic fl uid was divided into two 
parts, one part was used for interphase 
FISH and the other was used to establish 
two primary cultures for conventional 
cytogenetic analysis. Standard culture 
and harvest methods, described by 
Rooney and Czepulkowski7 were used 
to obtain chromosome preparations. 
G-banding on all the samples was per-
formed using the method of Seabright.8
The FISH analyses were performed 
on uncultured amniocytes, using DNA 
probes specifi c for chromosome 13,18, 
21, X, Y (Aneuvision, Vysis, Downers 
Grove, Ill., USA). 
RESULTS                                                      
The results of present study could be 
summarized in the following points:
- Age distribution among the enrolled 
mothers:
In 34 cases maternal ages were less 
than 35 years (85%) and in 6 cases ma-
ternal age was above 35 years (15%) 
for whom age distribution were as fol-
lows: 3 cases were from 36 to 37 years 
(7.5%) and 2 cases were from 38 to 39 
years (5%) and one case was above 39 
years (2.5%).
- Indications of amniocentesis for the 
enrolled mothers:
From all 40 enrolled mothers, 3l moth-
ers (77.5%) had a previous child with 
a chromosomal abnormality of which 
28 mothers (70%) had a pervious Down 
syndrome (Non-disjunction type) and 
one mother (2.5%) had a pervious child 
with  trisomy 18 and 2 mothers (5%) had 
a pervious child with structural chro-
mosomal abnormalities [46, XX, der 
(15)t(15; 21) mat, 46,XX, t(5;20) mat]. 
Advanced maternal age (above 35years) 
was indication for aminocentesis in 6 
mothers (15%) and in 2 cases (5%) in-
dication was abnormal ultrasound scan 
suggestive of aneuploidy [increased 
nucheal trasnsleucency (3mm) in one 
case and huge cystic hygroma in the 
other] and in one case (2.5%) indication 
for aminocentesis was paternal chro-
mosomal abnormality [46, XY, inv (9) 
(p11:q13)]. 
- Timing of amniocentesis:
Amniocentesis was performed between 
14 to 18 weeks of gestation, (Table 1).
Table 1: Timing of amniocentesis.
Timing of amniocentesis No. %
14-15 weeks 33 82.5
16-17 weeks 6 15
18 weeks 1 2.5
Results:
- Results of conventional karyotyp-
ing of cultured aminocytes for the en-
rolled mothers:
Normal karyotype was detected in 35 
cases (87.5%) and in 4 cases (10%) 
the following abnormalities were de-
tected: One case (2.5%) [47, XX, +21] 
(Figure. 1) and one case (2.5%) [46, 
XX, t (5;20) mat] (Figure. 2), one case 
(2.5%) [46, XX add 21 (q22)] (Figure. 
3) and one case (2.5%) [46, XY, inv 
(9) (q11:q13)] (Figure. 4). The culture 
failed in one case (2.5%), (Table 2).
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Fig. 1: Conventional karyotype of cultured amniocytes showing 47, XX, + 21 (Down syndrome).
Fig. 2: Conventional karyotype of cultured amniocytes Showing 46, XX, t (5;20) (p13;p13).
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Fig. 3: Conventional karyotype of cultured amniocytes showing 46, XX, add (21) (q22).
Fig. 4: Conventional karyotype of cultured amniocytes showing 46, XY, inv(9) (p11:q13).
32
Prenatal diagnosis of aneuploidy among a sample of Egyptian high risk pregnancies




The results of conventional karyotype
Failure Normal
Abnormal
No. Type of abnormality
Previous child with chromosomal abnormalities
Previous child with Trisomy 21• 
Previous child with Trisomy 18• 
Previous child with der(5)t(5;20)mat.• 
























Advanced maternal age 6 - 6 -
Abnormal US scan suggestive of aneuploidy
Increased nucheal translucency• 






















1 46,XY, inv (9) 
Total 40 1 35 4
- Results of FISH for the enrolled 
mothers:
Results of FISH confi rmed cytogenetic 
fi ndings of conventional karyotyping, 
for the probes used, on interphase nu-
clei in all the cases analysed, (one case 
with trisomy 21) (Figure. 5) except 
three cases of structural chromosomal 
abnormalities [46,XY, inv(9p11:q13)-
46, XX, t(5;20) (q13;p13) - 46,XX, add 
(21) (q22)] where this FISH protocol 
was not designed to detect them.




DISCUSSION                                                     
Prenatal diagnosis using amniotic fl uid 
for analyzing chromosomal disorders 
has become a standardized approach 
for certain indications in highly devel-
oped countries worldwide. The amniot-
ic fl uid contains fetal cells, which have 
to be cultivated. After culture times of 
1–3 weeks, a cytogenetic analysis can 
be performed. This time-consuming 
procedure may be quite distressful in 
many situations, not only for the preg-
nant woman but also for the gynecolo-
gist. Because cell cultivation is time 
consumptive, many attempts have been 
made to analyse chromosomes with-
out prior cell culture. As a fi rst step in 
this direction, a rapid partial karyotype 
analysis can be performed by using fl u-
orescence in situ hybridisation (FISH) 
with chromosome specifi c DNA probes 
on uncultured amniotic cells. Hereby 
up to 90% of all chromosomal disorders 
expected in the second trimester can be 
discovered theoretically within 24 h if 
DNA probes specifi c for chromosomes 
21, 18, 13, X and Y are used.9
Rapid detection of prenatal aneuploidy 
using interphase FISH on a large scale 
were successfully initiated by Klinger 
et al.10  and Ward et al.11. Their studies 
constituted the basis of the clinical pro-
tocols for the application of FISH for 
prenatal diagnosis. However, the forego-
ing two and most of the other studies11-17 
had several obstacles that delayed wide 
acceptance of FISH as a highly reliable 
method for routine prenatal diagnosis. 
Some authors used probes prepared by 
their own laboratories.10,11
Most cytogenetic laboratories are not 
qualifi ed and equipped to synthesize 
DNA probes and to perform necessary 
quality control studies. Furthermore, 
the assay conditions should be modi-
fi ed for each set of probes because the 
quality and characteristics of the probes 
are the key factors for successful FISH 
analysis.18
In the current study, indications for 
prenatal diagnosis in a sample of Egyp-
tian high risk pregnant woman for 
aneuploidy were as follow: Pervious 
child with chromosomal abnormalities 
in 31 cases (77.5%), of them 28 cases 
(70%) had pervious child with Down 
syndrome, one case (2.4%) had pervi-
ous child with trisomy 18 and 2 cases 
(4.7%) with history of pervious child 
with structural chromosomal abnor-
malities [one with t (5; 20), balanced) 
and the other with der (15), t (15; 21) 
(unbalanced)] in both cases periph-
eral blood lymphocytic culture were 
done for both parents. In both cases the 
mother was found to be a balanced car-
rier for the same translocation. Other 
indications was advanced maternal age 
in 6 cases (15%), abnormal US sugges-
tive of aneuploidy in 2 cases (5%) and 
paternal chromosomal abnormality in 
one case (2.5%).
The criteria for abnormal ultrasound 
scan included 1st and 2nd trimester ab-
normalities. During the 1st trimester, 
cystic hygroma and hydrops were con-
sidered as major markers of fetal aneu-
ploidy19. Other structural abnormalities 
considered as potential markers of fetal 
aneuploidy during the 1st trimester were 
also searched for including increased 
nuchal translucency, anomalies of the 
central nervous system as holoprosen-
cephaly, omphalocele, extremity ab-
normalities and major cardiac defects. 
During the 2nd trimester, cystic hygroma 
and hydrops were also considered as 
major markers of fetal aneuploidy. Oth-
er structural abnormalities including 
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nuchal thickening, echogenic bowel, 
short extremities, pyelectasis, intracar-
daic echogenic focus, ventricular dila-
tation, choroid plexus cyst, clinodactly, 
wide pelvic angle were considered as 
potential markers of fetal aneuploidy 
during the second trimester.20
Out of the 40 studied cases, there were 
only two cases that showed U/S abnor-
malities. The 1st trimester ultrasonogra-
phy of one of them revealed increased 
nuchal transleucency (3mm), for which 
the result of conventional karyotype and 
FISH were normal. In the other case, 
huge cystic hygroma was detected by 
2nd trimester ultrasonud and referred for 
possible prenatal diagnosis of aneuop-
loidy but the result of conventional 
karyotype and FISH were normal for 
both of them.
As regards increased nuchal transleu-
cency, a series of screening studies in 
high-risk pregnancies were carried out; 
these involved measurement of nuchal 
translucency thickness immediately be-
fore fetal karyotyping, mainly for ad-
vanced maternal age. Pandya et al.21 ex-
amined a total of 1273 pregnancies and 
reported that the nuchal translucency 
thickness was above the 95th centile of 
the normal range in about 80% of tri-
somy 21 fetuses. Similar fi ndings were 
obtained in an additional four studies of 
pregnancies undergoing fi rst-trimester 
fetal karyotyping22-25. However, in an-
other study involving 1819 pregnan-
cies, nuchal translucency thickness of 
equal to or greater than 3mm identifi ed 
only 30% of the chromosomally abnor-
mal fetuses and the false-positive rate 
was 3.2%.26 
As regards cystic hygroma, Bronshtein 
et al.27 found that in comparison with 
non-septated cystic spaces (nucheal 
thickness), septated cystic hygromas 
were much more likely to be persistent 
(56% versus 2%) and associated with 
aneupolidy (72% versus 5.6%). Nadel 
et al.28 found that Cystic hygromas were 
associated with fetal aneupolidy in ap-
proximately 75% of cases, of which 
Turner’s syndrome (45, X) was most 
common and that fetuses with Turner’s 
syndrome had larger cystic hygromas 
than those with triosmy 18, trisomy 21, 
or normal karyotype.
In the current study, the FISH assay 
confi rmed the cytogenetic fi ndings, 
for the probes used, on interphase nu-
clei and in metaphase spreads in all 
the cases analysed, except three cases 
of structural chromosomal abnormali-
ties [46, XX, add (21)q (22), 46, XX, 
t(5;20) mat, 46, XY, inv (9) (p11:q13)] 
paternal for which this FISH protocol 
was not designed to detect. In one case 
of culture contamination, FISH analysis 
was useful in excluding the aberrations 
of specifi c chromosomes 13, 18, 21, X 
and Y on the uncultured/interphase nu-
clei. One case of Down syndrome was 
identifi ed by interphase FISH and also 
confi rmed by cytogenetic analysis. The 
study was also designed to compare the 
FISH assay with conventional cytoge-
netic analysis and on this basis to evalu-
ate the clinical utility of the assay for 
prenatal diagnosis of aneuploidies.
Several studies demonstrated an ex-
tremely high concordance rate between 
results of FISH and standard cytogenet-
ics (99.8%) for prenatal diagnosis of 
aneuploidy for chromosomes 13,18, 21, 
X and Y that the AneuVysion assay is 
designed to detect.29
In a study conducted by Jobanputra et 
al.30 prenatal diagnosis was carried out 
in 88 high-risk pregnancies using FISH 
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and cytogenetic analysis. Multicolour 
commercially available FISH probes 
specifi c for chromosomes 13, 18, 21, X 
and Y were used. The results of FISH 
were in conformity with the results of 
cytogenetic analysis in all the normal 
and aneuploid cases except in one case 
of structural chromosomal abnormality. 
The hybridization effi ciency of the 5 
probes used for the detection of aneu-
ploidies was 100%.30
In another study conducted by Ha-
Jung et al.31 using amniotic fl uid inter-
phase fl uorescence in situ hybridization 
(FISH) for detection of aneuploidy in 
130 prenatal cases using DNA probes 
specifi c for chromosome 13, 18, 21, X, 
Y. The overall detection rate for aneu-
ploidies was 100% and in comparison 
to conventional cytogenetic results, the 
rates of both sensitivity and specifi city 
were 100 %.31
A Quantitative fl uorescence-PCR (QF-
PCR) approach is a more recent ad-
dition to aneuploidy diagnosis. The 
technique involves the relative quan-
tifi cation of microsatellite alleles to 
determine sequence copy number; am-
plifi cation using fl uorescence-labelled 
primers is followed by size separation 
and allele peak measurement on a semi-
automated genetic analyser. Several as-




FISH provides rapid, sensitive, specifi c 
and reliable, cost-effective method of 
prenatal diagnosis of numerical abnor-
malities of chromosomes 13, 18, 21, X 
and Y in conjunction with other methods 
currently used in prenatal diagnosis of 
high risk pregnancies for aneuploidy. 
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